A

ABIVAX
ABVX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€388.05M
EV
€352.91M
Shares Outstanding
63.41M
Beta
1.56

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€25.43
P/E 2025E
-
P/Revenue 2025E
52.88x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ABIVAX Société Anonyme

gainify

A

ABIVAX Société Anonyme

ABVX

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead ...

Sector

Healthcare

Industry

Biotechnology

CEO

de Garidel, Marc M.

Employees

69

IPO Date

2015-06-26

Headquarters

7-11 boulevard Haussmann, Paris, Ile-de-France, 75009, France

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved